Procedureless Gastric Balloon Encourages Weight Loss 
|
By HospiMedica International staff writers Posted on 23 Dec 2015 |
|
Image: The Elipse procedureless gastric balloon (Photo courtesy of Allurion Technologies).S
An innovative gastric balloon offers an alternative treatment option for overweight and obese individuals.
The Elipse procedureless gastric balloon is a thin, flexible polymer film balloon that is delivered in a swallowable capsule, thus eliminating the need for surgery, endoscopy, or anesthesia. Once in position, it is filled with liquid through a thin delivery catheter, which is then detached by tugging. The gastric balloon remains in the stomach for four months, after which it automatically empties and is excreted naturally from the body. The Elipse will be offered by physicians in conjunction with a medically supervised diet and exercise program.
The Elipse has undergone clinical studies in people with a body mass index (BMI) of 27-40 kg/m2. Study findings indicated an average weight loss of 10 kilograms, with participants losing 37% of their excess weight and eight centimeters off their waist circumference over the four month treatment period. Participants also saw improvements in triglyceride and hemoglobin HbA1c levels, and all balloons were safely and naturally excreted. The Elipse procedureless gastric balloon is a product of Allurion Technologies (Wellesley, MA, USA), and has received the European Community CE marking of approval.
“Excess weight often has a profound impact on health and quality of life, including work, relationships, and self-perception. But of nearly two billion overweight and obese adults worldwide, less than one percent have embraced currently available surgical and endoscopic options,” said Shantanu Gaur, MD, co-founder and chief scientific officer of Allurion Technologies. “Weight loss therapies that require surgery, endoscopy, or anesthesia are often too invasive and can be too expensive for people who might otherwise greatly benefit from them.”
“Following six years of development, we are very excited to enter the next phase of our company's growth,” said Jonathan Wecker, CEO of Allurion Technologies. “I am extremely proud of our team and thankful for the support of the many physicians and allied caregivers that have helped make Elipse a reality.”
Related Links:
Allurion Technologies
The Elipse procedureless gastric balloon is a thin, flexible polymer film balloon that is delivered in a swallowable capsule, thus eliminating the need for surgery, endoscopy, or anesthesia. Once in position, it is filled with liquid through a thin delivery catheter, which is then detached by tugging. The gastric balloon remains in the stomach for four months, after which it automatically empties and is excreted naturally from the body. The Elipse will be offered by physicians in conjunction with a medically supervised diet and exercise program.
The Elipse has undergone clinical studies in people with a body mass index (BMI) of 27-40 kg/m2. Study findings indicated an average weight loss of 10 kilograms, with participants losing 37% of their excess weight and eight centimeters off their waist circumference over the four month treatment period. Participants also saw improvements in triglyceride and hemoglobin HbA1c levels, and all balloons were safely and naturally excreted. The Elipse procedureless gastric balloon is a product of Allurion Technologies (Wellesley, MA, USA), and has received the European Community CE marking of approval.
“Excess weight often has a profound impact on health and quality of life, including work, relationships, and self-perception. But of nearly two billion overweight and obese adults worldwide, less than one percent have embraced currently available surgical and endoscopic options,” said Shantanu Gaur, MD, co-founder and chief scientific officer of Allurion Technologies. “Weight loss therapies that require surgery, endoscopy, or anesthesia are often too invasive and can be too expensive for people who might otherwise greatly benefit from them.”
“Following six years of development, we are very excited to enter the next phase of our company's growth,” said Jonathan Wecker, CEO of Allurion Technologies. “I am extremely proud of our team and thankful for the support of the many physicians and allied caregivers that have helped make Elipse a reality.”
Related Links:
Allurion Technologies
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Emergency Ventilator
Shangrila935
Hemostatic Agent
HEMOBLAST Bellows
Latest Surgical Techniques News
- Breakthrough Brain Implant Enables Safer and More Precise Drug Delivery
- Bioadhesive Sponge Stops Uncontrolled Internal Bleeding During Surgery
- Revolutionary Nano Bone Material to Accelerate Surgery and Healing
- Superior Orthopedic Implants Combat Infections and Quicken Healing After Surgery
- Laser-Based Technique Eliminates Pancreatic Tumors While Protecting Healthy Tissue
- Surgical Treatment of Severe Carotid Artery Stenosis Benefits Blood-Brain Barrier
- Revolutionary Reusable Duodenoscope Introduces 68-Minute Sterilization
- World's First Transcatheter Smart Implant Monitors and Treats Congestion in Heart Failure
- Hybrid Endoscope Marks Breakthrough in Surgical Visualization
- Robot-Assisted Bronchoscope Diagnoses Tiniest and Hardest to Reach Lung Tumors
- Diamond-Titanium Device Paves Way for Smart Implants that Warn of Disease Progression
- 3D Printable Bio-Active Glass Could Serve as Bone Replacement Material
- Spider-Inspired Magnetic Soft Robots to Perform Minimally Invasive GI Tract Procedures
- Micro Imaging Device Paired with Endoscope Spots Cancers at Earlier Stage
- AI Spine Model Could Reduce Surgical Risks
- Novel Method Uses Interstitial Fluid Flow to Predict Where Brain Tumor Can Grow Next
Channels
Critical Care
view channel
Improved Cough-Detection Technology Aids Health Monitoring
Coughing serves as an important biomarker for tracking a variety of conditions and can help monitor the progress of respiratory diseases or predict when someone’s asthma is being exacerbated.... Read more
AI Identifies Children in ER Likely to Develop Sepsis Within 48 Hours
Sepsis, a severe infection that causes life-threatening organ dysfunction, remains one of the leading causes of death among children worldwide. Early identification is critical, yet the condition can develop... Read more
New Radiofrequency Therapy Slows Glioblastoma Growth
Glioblastoma is an aggressive and often treatment-resistant brain cancer with few effective therapeutic options. Standard treatments frequently fail to eliminate tumor stem cells that drive recurrence... Read more
Battery-Free Wireless Multi-Sensing Platform Revolutionizes Pressure Injury Detection
Pressure injuries are a common and painful condition among elderly and immobile patients, often caused by prolonged pressure that damages skin tissue. Contact with bio-contaminants such as urine or feces... Read morePatient Care
view channel
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
VR Training Tool Combats Contamination of Portable Medical Equipment
Healthcare-associated infections (HAIs) impact one in every 31 patients, cause nearly 100,000 deaths each year, and cost USD 28.4 billion in direct medical expenses. Notably, up to 75% of these infections... Read more
Portable Biosensor Platform to Reduce Hospital-Acquired Infections
Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read moreHealth IT
view channel
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read more
Business
view channel
Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies
Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
B. Braun Acquires Digital Microsurgery Company True Digital Surgery
The high-end microsurgery market in neurosurgery, spine, and ENT is undergoing a significant transformation. Traditional analog microscopes are giving way to digital exoscopes, which provide improved visualization,... Read more
CMEF 2025 to Promote Holistic and High-Quality Development of Medical and Health Industry
The 92nd China International Medical Equipment Fair (CMEF 2025) Autumn Exhibition is scheduled to be held from September 26 to 29 at the China Import and Export Fair Complex (Canton Fair Complex) in Guangzhou.... Read more